Page 47 - Ram Prasad Sahu

Upside for Tata Communications hinges on data growth, esp newer segments

Land monetisation could be a short term trigger

New launches, market share gains to sustain Gland Pharma's sales trajectory

Earnings are expected to grow over 25 per cent over the next two years

Top listed developers sitting pretty after record bookings in Dec quarter

Experts expect further market share gains; cash flows and collections likely to improve

Market share gains in India, Europe positive for Endurance Technologies

Consistent growth in the Indian two-wheeler and European car markets is key

Demand trajectory, valuations weigh on Page Ind despite stellar Q3 show

The company posted a strong Q3 led by higher athleisure sales

Weak Q3 show, margin pressures to keep Sanofi stock under pressure

Growth led by power brands and new launches could recover as pandemic impact wanes

Margin pressures may offset volumes gains for Schaeffler

Higher content per vehicle, steady aftermarket and exports are growth drivers

Mahindra CIE: Margin gains, recovery in Europe biz key for the stock

To derisk the electric vehicle risk in Europe, the company is looking at increasing its market share in crankshafts, non-engine parts such as steering knuckle and aluminium forgings

India business drives strong Q3 margin performance for Mahindra CIE

The management expects profitability to improve on the back of volumes, cost reduction

Pricing, ad spends to sustain P&G Hygiene's out-performance in near term

Brokerages have upgraded the stock on expectations of double digit growth

Weak Q3, downgrades to keep Bayer CropScience stock under pressure

Given the focus on volume growth and price cuts margin pressures may remain

Asset monetisation, sales uptick in US key triggers for Glenmark Pharma

The India business is expected to post double digit growth in FY22

Higher EV share, FY22 auto rebound to support Motherson's revenues

Increased utilisation, improving margins and lower debt are profit triggers going ahead

Apollo Hospitals to step up pharmacy, retail biz, eyes Rs 10,000 cr revenue

Core hospital segment too is looking up on the back of rise in occupancies, footfalls

Recovery in occupancy, footfalls drive growth for Apollo Hospitals

The ramp up in new hospitals should add to revenues and margins going ahead for the hospitals segment

Higher EV share, FY22 auto rebound to support Motherson Sumi's revenues

Increased utilisation, improving margins and lower debt are profit triggers going ahead

Cautious India CV outlook could keep Bharat Forge stock under pressure

Company's new initiatives and plans to offset weak oil and gas revenues may take time to play out

Aurobindo Pharma steady as analysts watch numbers for near-term growth

The company's investments across segments will take at least two years to play out, say analysts

Auto margins could come under near-term pressure on higher duties

Commercial vehicle companies to gain the most on scrappage, bus orders and infra boost

Tata Motors hits profit after three quarters, net zooms 67% to Rs 2,906 cr

JLR posts its highest free cash flows in Q3